Clinical trial
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
NCT00483119 · NYU Langone Health, Other · Terminated
Key facts
| NCT number | NCT00483119 |
|---|---|
| Title | Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus |
| Official title | Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus |
| Lead sponsor | NYU Langone Health, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pemphigus Vulgaris |
| Intervention type | Drug |
| Interventions | intravenous immunoglobulin, cyclophosphamide |
| Enrollment | 9 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Jun 6, 2007 |
| Last update posted | Feb 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: